Cannabis stocks rise ahead of potential Trump order to ease marijuana restrictions
Reuters· 2025-12-18 14:14
Shares of cannabis firms rose in premarket trading on Thursday, driven by expectations that U.S. President Donald Trump will sign an executive order easing federal regulations on marijuana. ...
IRSA: Monetizing Ramblas
Seeking Alpha· 2025-12-18 14:14
I met with Inversiones y Representaciones Sociedad Anónima, or IRSA's ( IRS ) management, last week as part of my formal position. While I had not paid much attention to the company since the pandemic, I had coveredI have more that 35 years of experience in the investment field having worked as a sell & buy side analyst and portfolio manger for debt and equity funds. I am currently managing a high yield Latam bond fund.My goal, as a Seeking Alpha contributor, is to provide a fundamental view and analysis of ...
CHITOSE and FUJIFILM Biosciences Form Strategic Alliance to Drive Global Innovation and Biopharmaceutical Manufacturing
Businesswire· 2025-12-18 14:13
The collaboration brings together the unique strengths of both companies to improve the way medicines are produced, supporting the development of new therapies for patients worldwide and helping more people access life-saving treatments. KAWASAKI, Japan & SANTA ANA, Calif.--(BUSINESS WIRE)--Chitose Laboratory Corp., (CHITOSE), a leading company of the bioeconomy and provider of advanced cell line development services, and FUJIFILM Biosciences Inc., a global leader in the innovation and manufacture of cell c ...
NVDA, AVGO and ORCL Forecast – Major Tech Stocks Look to Recover on Thursday
FX Empire· 2025-12-18 14:13
Core Viewpoint - The content emphasizes the importance of conducting personal due diligence and consulting with competent advisors before making any financial decisions, particularly in the context of investments in complex instruments like cryptocurrencies and CFDs [1]. Group 1 - The website provides general news, personal analysis, and opinions, as well as materials from third parties for educational and research purposes [1]. - It explicitly states that the information should not be interpreted as a recommendation or advice for any financial actions, including investments or purchases [1]. - The accuracy and reliability of the information are not guaranteed, and users are cautioned that prices may be provided by market makers rather than exchanges [1]. Group 2 - The content highlights the high risk associated with cryptocurrencies and CFDs, noting that they are complex instruments that can lead to significant financial losses [1]. - Users are encouraged to conduct their own research and fully understand the workings and risks of any financial instruments before investing [1].
BioHarvest gets $1.6M Israeli grant to advance botanical synthesis technology
Proactiveinvestors NA· 2025-12-18 14:12
About this content About Angela Harmantas Angela Harmantas is an Editor at Proactive. She has over 15 years of experience covering the equity markets in North America, with a particular focus on junior resource stocks. Angela has reported from numerous countries around the world, including Canada, the US, Australia, Brazil, Ghana, and South Africa for leading trade publications. Previously, she worked in investor relations and led the foreign direct investment program in Canada for the Swedish government ...
US Core CPI Eases in November to Slowest Pace Since 2021
Youtube· 2025-12-18 14:12
Well, better late than never is a good way to put it, Lisa, because the news is pretty good on a two month basis. Remember, we didn't get October CPI and we're not going to get much out of that 2.7% for the year over year move in CPI. That is down from 3% in September.The last release we got the core CPI on a year over year basis falls from 3% to 2.6%. So good news on inflation. Meanwhile, good news on the job front with initial jobless claims falling to 224,000 from 237,000 revised the week prior.On a cont ...
NextDecade Corporation: Planned Construction Completion Likely To Meet Demand Surge By 2027
Seeking Alpha· 2025-12-18 14:11
It has not been a smooth ride for natural gas liquefier NextDecade Corporation ( NEXT ), whose shares have declined 24.22% year-over-year (YoY) and 33.46% year-to-date (YTD). However, what caught my eye is that the company has been growing its cash reserves atI have more than five years experience in the financial industry. I focus mostly in the commodities, foreign exchange and cryptocurrencies. I also write on general issues like equity research, economics and geopolitics.Fellow contributor Crispus Nyaga ...
Darden Restaurants (DRI) Q2 Earnings Lag Estimates
ZACKS· 2025-12-18 14:11
Darden Restaurants (DRI) came out with quarterly earnings of $2.08 per share, missing the Zacks Consensus Estimate of $2.09 per share. This compares to earnings of $2.03 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -0.48%. A quarter ago, it was expected that this owner of Olive Garden and other chain restaurants would post earnings of $2 per share when it actually produced earnings of $1.97, delivering a surprise of -1.5%.O ...
FactSet Research (FDS) Q1 Earnings and Revenues Top Estimates
ZACKS· 2025-12-18 14:11
FactSet Research (FDS) came out with quarterly earnings of $4.51 per share, beating the Zacks Consensus Estimate of $4.39 per share. This compares to earnings of $4.37 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +2.73%. A quarter ago, it was expected that this financial data firm would post earnings of $4.15 per share when it actually produced earnings of $4.05, delivering a surprise of -2.41%.Over the last four quarters, ...
Netflix vs. Paramount: What you need to know about the bidding war for Warner Bros.
Fastcompany· 2025-12-18 14:11
Core Viewpoint - Warner Bros. is advocating for shareholders to reject a hostile takeover bid from Paramount Skydance in favor of a $72 billion buyout offer from Netflix, which it considers superior [1][5]. Group 1: Offers and Valuations - Paramount's offer is $30 per share, valuing Warner Bros. at approximately $77.9 billion, while Netflix's offer is $27.75 per share, valuing Warner at $72 billion [1][5][6]. - Paramount's bid includes a cash component and aims to acquire Warner's cable assets, which Netflix's offer does not include [5][6]. - Paramount claims its offer is about $18 billion more in cash than Netflix's bid [5]. Group 2: Regulatory Scrutiny - Both offers are expected to face intense scrutiny from U.S. regulators due to their potential impact on the entertainment landscape, including movie production and consumer streaming platforms [2][3][13]. - Concerns regarding the Netflix offer center around the size of the combined subscription service, as Netflix is already the largest streaming service globally [13][14]. - The Paramount deal may raise regulatory concerns regarding the consolidation of film and television studios, given the limited number of such entities remaining in the market [14]. Group 3: Market Dynamics - The competition between Netflix and Paramount for Warner Bros. highlights the ongoing consolidation trend in the media industry, as companies seek growth through acquisitions [15][16]. - The involvement of high-profile investors, including Jared Kushner and funds from Saudi Arabia and Qatar, adds complexity to the Paramount bid [6][12]. - Analysts suggest that the presence of competing offers increases the likelihood of Warner Bros. being acquired, as it shifts the decision-making landscape [9].